Physician profile
David C Leech
NPI 1831167410
$485.15
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $126 · 2020: $122 · 2021: $69.86 · 2022: $73.15 · 2023: $79.89 · 2024: $15.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $94.97.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $94.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $125.53 | 2019 | |
| Amarin Pharma, INC. | $74.65 | 2020-2021 | |
| Nestle Healthcare Nutrition INC. | $45.55 | 2021 | |
| Pfizer INC. | $37.92 | 2020 | |
| Amgen INC. | $35.69 | 2022 | |
| Astellas Pharma US INC | $31.54 | 2022-2023 | Myrbetriq |
| Abbott Laboratories | $29.09 | 2023-2024 | Freestyle Libre 2 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.71 | 2023 | Trulance, Xifaxan |
| Neurocrine Biosciences, INC. | $20.36 | 2023 | Ingrezza |
| Abbvie INC. | $20.32 | 2020 | |
| Merck Sharp & Dohme LLC | $13.06 | 2021 | |
| Lilly USA, LLC | $12.93 | 2022 | |
| Novartis Pharmaceuticals Corporation | $11.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Leech listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.